PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
1-Year Return
16.62%
This Quarter Return
+14.58%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$1.5B
AUM Growth
-$222M
(-13%)
Cap. Flow
-$441M
Cap. Flow
% of AUM
-29.34%
Top 10 Holdings %
Top 10 Hldgs %
51.88%
Holding
131
New
16
Increased
28
Reduced
47
Closed
16
Top Buys
| 1 |
Rogers Communications
RCI
|
$77.7M |
| 2 |
Adobe
ADBE
|
$68.8M |
| 3 |
Yum! Brands
YUM
|
$64.4M |
| 4 |
Johnson & Johnson
JNJ
|
$61.6M |
| 5 |
IQVIA
IQV
|
$61.6M |
Top Sells
| 1 |
ZTO Express
ZTO
|
$137M |
| 2 |
Schlumberger
SLB
|
$88M |
| 3 |
TransUnion
TRU
|
$87.8M |
| 4 |
Cameco
CCJ
|
$72.3M |
| 5 |
Broadcom
AVGO
|
$66.7M |
Sector Composition
| 1 | Healthcare | 22.58% |
| 2 | Technology | 21.72% |
| 3 | Financials | 16.54% |
| 4 | Communication Services | 15.72% |
| 5 | Consumer Discretionary | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pinduoduo
PDD
$177B
| $9.26M | 0.62% |
88,509
-21,746
| -20% | -$2.28M |
|
27
Visa
V
$683B
| $8.95M | 0.6% |
25,209
-1,106
| -4% | -$393K |
|
28
Amer Sports
AS
$20.8B
| $7.36M | 0.49% |
190,000
-10,000
| -5% | -$388K |
|
29
Zoetis
ZTS
$67.4B
| $6.24M | 0.41% |
40,000
| – | – |
|
30
Huazhu Hotels Group
HTHT
$11.2B
| $6.21M | 0.41% |
183,111
-65,127
| -26% | -$2.21M |
|
31
Birkenstock
BIRK
$9.25B
| $5.9M | 0.39% |
120,000
| – | – |
|
|
XYZ
32
Block, Inc.
XYZ
$46.2B
| $5.43M | 0.36% |
80,000
-22,959
| -22% | -$1.56M |
|
33
Roivant Sciences
ROIV
$8.71B
| $5.42M | 0.36% |
481,335
-14,462
| -3% | -$163K |
|
34
CoStar Group
CSGP
$37.3B
| $5.23M | 0.35% |
65,000
| – | – |
|
35
e.l.f. Beauty
ELF
$7.61B
| $4.98M | 0.33% |
40,000
| – | – |
|
36
Microsoft
MSFT
$3.77T
| $4.65M | 0.31% |
9,340
| – | – |
|
37
NVIDIA
NVDA
$4.15T
| $4.64M | 0.31% |
29,399
+4,920
| +20% | +$777K |
|
38
Netflix
NFLX
$533B
| $4.22M | 0.28% |
3,152
-466
| -13% | -$624K |
|
|
CNTA
39
Centessa Pharmaceuticals
CNTA
$2.13B
| $3.82M | 0.25% |
290,836
+22,949
| +9% | +$302K |
|
40
Vera Therapeutics
VERA
$1.39B
| $3.76M | 0.25% |
159,751
+20,433
| +15% | +$481K |
|
41
Apogee Therapeutics
APGE
$2.2B
| $3.76M | 0.25% |
86,512
-9,134
| -10% | -$397K |
|
42
ADC Therapeutics
ADCT
$360M
| $3.72M | 0.25% |
1,387,265
-650,822
| -32% | -$1.74M |
|
43
Veeva Systems
VEEV
$44B
| $3.64M | 0.24% |
12,646
-3,862
| -23% | -$1.11M |
|
44
IDEAYA Biosciences
IDYA
$2.23B
| $3.51M | 0.23% |
166,917
+14,204
| +9% | +$299K |
|
45
BridgeBio Pharma
BBIO
$9.8B
| $3.27M | 0.22% |
75,708
+5,358
| +8% | +$231K |
|
46
Immunovant
IMVT
$2.86B
| $3.13M | 0.21% |
195,727
+38,738
| +25% | +$620K |
|
47
JD.com
JD
$43.8B
| $3.02M | 0.2% |
92,596
-336,492
| -78% | -$11M |
|
48
Zymeworks
ZYME
$1.07B
| $2.99M | 0.2% |
238,391
-40,267
| -14% | -$505K |
|
49
ProQR Therapeutics
PRQR
$244M
| $2.96M | 0.2% |
1,450,969
-87,278
| -6% | -$178K |
|
50
Cadence Design Systems
CDNS
$95.2B
| $2.56M | 0.17% |
8,297
+1,960
| +31% | +$604K |
|